Recent Updates
- Protein — high-dose strategy retired (2023–2024): EFFORT Protein (2023) and PRECISe (2024) found that high protein (≥2 g/kg/day) does not improve survival or recovery and may worsen outcomes — including a mortality signal in acute kidney injury not on dialysis. ESPEN 2023 now targets ~1.3 g/kg/day and discourages higher doses.
- Permissive underfeeding in acute shock (NUTRIREA-3, 2023): early low-calorie/low-protein feeding caused fewer GI complications with no survival penalty, supporting conservative feeding in the first days of critical illness.
- Guidelines: the ASPEN 2022 focused update and ESPEN 2023 revision both endorse conservative early energy (12–25 kcal/kg/day, or ≤70% of measured expenditure acutely), early enteral nutrition, and delayed supplemental parenteral nutrition.
Reignier J, et al. Lancet Respir Med. 2023;11(7):602–612 · Heyland DK, et al. Lancet. 2023;401:568–576 · Bels JLM, et al. Lancet. 2024;404:659–669 · Compher C, et al. JPEN. 2022;46(1):12–41 · Singer P, et al. Clin Nutr. 2023;42(9):1671–1689.
About This Nutrition Support Guide
This nutrition support guide integrates evidence from the ASPEN critical care guidelines (2016, focused update 2022) and the ESPEN ICU guideline (2019, revised 2023), together with major 2023–2025 randomized trials, to provide a comprehensive decision-support tool for hospitalized patients. It combines nutritional risk screening, calorie and protein target calculation, route selection (EN vs PN), product matching, refeeding risk assessment, and micronutrient recommendations into a single streamlined workflow for clinicians, dietitians, and nutrition support teams.
The guide covers both ICU and general ward patients, automatically adjusting screening tools (mNUTRIC for ICU, NRS-2002 for ward), calorie ranges, and monitoring protocols based on the clinical setting. It is designed as a clinical decision-support tool and all recommendations should be individualized based on each patient’s full clinical context.
How to Use This Guide
Step 1: Enter the patient’s clinical setting (ICU or General Ward), age, sex, height, and actual body weight. The guide automatically calculates BMI, Ideal Body Weight (IBW), and Adjusted Body Weight for obese patients.
Step 2: Select all applicable clinical conditions from the checklist. These conditions directly influence protein targets, formula selection, and monitoring recommendations.
Step 3: Complete the nutritional risk screening (mNUTRIC for ICU, NRS-2002 for General Ward) and refeeding risk assessment.
Step 4: Select the nutrition route (EN, PN, or EN+PN). The guide provides automatic recommendations based on the clinical scenario but allows manual override.
Step 5: Click “Calculate” to generate a complete nutrition support plan including calorie/protein targets (ASPEN & ESPEN), EN/PN product recommendations, micronutrient needs, and monitoring checklists.
Clinical Interpretation & Limitations
This guide provides evidence-based ranges rather than single-point recommendations. The dual display of ASPEN and ESPEN targets reflects the reality that different institutions may follow different guidelines, and clinical teams should select the most appropriate targets for their patient population and practice setting.
Recent evidence (2023–2025): Several large randomized trials have refined nutrition practice. NUTRIREA-3 (2023) found that early conservative (low-calorie, low-protein) feeding in shock caused fewer GI complications with no survival penalty, supporting permissive underfeeding in the acute phase. EFFORT Protein (2023) and PRECISe (2024) showed that high protein delivery (≥2 g/kg/day) does not improve outcomes and may worsen recovery — with a specific harm signal in acute kidney injury not on dialysis. ESPEN 2023 targets ~1.3 g/kg/day (ASPEN’s text still permits up to 2.0 but its 2022 update found no benefit to higher protein), so a conservative default with early enteral nutrition, advanced gradually, is now favored; condition-specific higher targets (e.g., burns, major trauma, CRRT) still apply.
Key limitations include: (1) Calorie and protein targets are estimates — indirect calorimetry remains the gold standard for measuring energy expenditure in critically ill patients. (2) EN and PN product databases contain estimated compositions that should be verified against local formulary and manufacturer package inserts. (3) The guide does not replace clinical judgment regarding timing of nutrition initiation, tolerance assessment, or individualized adjustments.
Frequently Asked Questions (FAQ)
Q: How do I determine calorie targets for hospitalized patients?
Calorie targets depend on BMI, clinical phase, and guideline preference. The ASPEN 2022 update found no outcome benefit from reaching full calories early and supports 12–25 kcal/kg/day during the first week of critical illness; ESPEN advises ≤70% of measured energy expenditure in the acute phase, advancing to 80–100% of measured expenditure after ~day 3, with full weight-based targets (~25–30 kcal/kg/day) in the recovery phase. Indirect calorimetry remains the gold standard when available. For obese patients (BMI ≥ 30), hypocaloric high-protein feeding is recommended.
Q: Has the high-protein recommendation changed?
Yes. Older guidance suggested up to 2.0 g/kg/day or more for critically ill patients. Randomized trials published in 2023–2024 (EFFORT Protein, PRECISe) found that higher protein does not improve survival or recovery and may cause harm — particularly slower recovery and higher mortality in acute kidney injury not on dialysis. ESPEN 2023 targets ~1.3 g/kg/day and discourages higher doses (ASPEN still permits up to 2.0 but found no benefit), so a conservative default is now favored for most critically ill patients, with higher amounts reserved for specific conditions (e.g., burns, major trauma, CRRT).
Q: What is the mNUTRIC score and when should it be used?
The modified NUTRIC (mNUTRIC) score is a validated nutritional risk screening tool for ICU patients. It incorporates age, APACHE II, SOFA score, comorbidities, and days from hospital to ICU admission. A score ≥ 5 indicates high nutritional risk requiring aggressive nutrition support.
Q: When should parenteral nutrition (PN) be started?
PN is indicated when the GI tract is non-functional or when EN alone cannot meet nutritional targets. Per ASPEN, if EN is not feasible, PN should be considered within 7 days for low-risk patients and started early (low-dose, avoiding overfeeding) in high-nutritional-risk or malnourished patients. Early supplemental PN added to EN should be delayed (EPaNIC, 2011).
Q: How is refeeding syndrome risk assessed?
Refeeding risk is assessed by BMI (below 16 indicates extreme risk), duration of fasting (10+ days), recent unintentional weight loss (10%+ in 3–6 months), and history of alcohol abuse or chronic diuretic use. High-risk patients should start nutrition at reduced calorie levels (5–10 kcal/kg/day) with aggressive electrolyte monitoring.
Q: What is the difference between ASPEN and ESPEN calorie recommendations?
Both guidelines now converge on conservative early feeding. The ASPEN 2022 update supports 12–25 kcal/kg/day during the first week (no benefit from early full calories), while ESPEN 2023 advises ≤70% of measured energy expenditure acutely, advancing to 80–100% of measured expenditure after ~day 3 (full weight-based ~25–30 kcal/kg/day in the recovery phase). For obese patients, ASPEN recommends 11–14 kcal/kg actual body weight and ESPEN ~20–25 kcal/kg adjusted body weight. This guide displays both frameworks so the clinical team can choose the most appropriate target.
Related Calculators
📖 Sources:
- Compher C, et al. (2022). Guidelines for the provision of nutrition support therapy in the adult critically ill patient: SCCM/ASPEN focused update. JPEN J Parenter Enteral Nutr, 46(1):12–41. DOI:10.1002/jpen.2267
- Singer P, et al. (2023). ESPEN practical and partially revised guideline: Clinical nutrition in the ICU. Clinical Nutrition, 42(9):1671–1689. DOI:10.1016/j.clnu.2023.07.011
- Reignier J, et al. (2023). Early nutrition in critically ill patients (NUTRIREA-3): a randomised controlled trial. Lancet Respir Med, 11(7):602–612.
- Heyland DK, et al. (2023). The EFFORT Protein trial: high vs usual protein in critically ill patients. Lancet, 401(10376):568–576.
- Bels JLM, et al. (2024). High vs standard enteral protein in critically ill patients (PRECISe): a randomised, double-blind trial. Lancet, 404(10454):659–669.
- McClave SA, et al. (2016). Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: SCCM and ASPEN. JPEN J Parenter Enteral Nutr.
- Singer P, et al. (2019). ESPEN guideline on clinical nutrition in the intensive care unit. Clinical Nutrition.
- Kondrup J, et al. (2003). Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clinical Nutrition.
- Heyland DK, et al. (2011). A novel nutritional adequacy tool for critically ill patients (NUTRIC score). Critical Care.
- NICE (2006, updated 2017). Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition. Clinical guideline CG32.
- Friedli N, et al. (2018). Management and prevention of refeeding syndrome in medical inpatients: An evidence-based and consensus-supported algorithm. Nutrition.
⚠️ Disclaimer:
This tool is for informational and educational purposes only and is not a substitute for professional clinical judgment. All treatment decisions must be made by a qualified healthcare professional considering the individual patient’s full clinical context. EN and PN product compositions are estimates and must be verified against manufacturer package inserts before clinical use.
